Share Price and Basic Stock Data
Last Updated: January 27, 2026, 10:06 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chennai Meenakshi Multispeciality Hospital Ltd operates in the Hospitals & Medical Services sector, focusing on providing diverse healthcare solutions. The company’s market capitalization stood at ₹31.8 Cr, with a share price of ₹42.6. Revenue trends indicate variability, with reported sales of ₹38.19 Cr for the financial year ending March 2023, a decline from ₹30.86 Cr in the previous year. The trailing twelve months (TTM) revenue is recorded at ₹36.12 Cr, suggesting a modest recovery. Quarterly sales figures reveal fluctuations, peaking at ₹10.07 Cr in December 2023 before declining to ₹8.75 Cr by June 2024. This inconsistent revenue performance raises concerns regarding the hospital’s ability to maintain steady growth amid competitive pressures in the healthcare sector.
Profitability and Efficiency Metrics
Chennai Meenakshi Multispeciality Hospital’s profitability metrics present a mixed picture. The company reported a net profit of ₹0.89 Cr in March 2023, which was a significant improvement over the loss of ₹1.25 Cr in March 2021. However, the net profit for March 2024 declined to a loss of ₹0.43 Cr, indicating ongoing challenges. Operating profit margin (OPM) stood at 7.93% for March 2023 but fell to -0.59% by March 2025. The interest coverage ratio (ICR) at 0.71x suggests the hospital struggles to cover its interest obligations, raising red flags about financial health. The cash conversion cycle (CCC) of -56.26 days indicates efficiency in managing working capital, but the overall profitability remains under pressure due to rising expenses, which totaled ₹35.16 Cr in March 2023, up from ₹25.12 Cr in March 2022.
Balance Sheet Strength and Financial Ratios
The balance sheet of Chennai Meenakshi Multispeciality Hospital reflects a precarious financial position with total borrowings of ₹10.63 Cr against reserves of -₹10.04 Cr, highlighting a negative net worth. The company’s total assets stood at ₹22.50 Cr as of March 2025, while total liabilities were reported at ₹22.81 Cr, indicating a highly leveraged situation. Key financial ratios such as the price-to-book value (P/BV) ratio of -12.21x and a current ratio of 0.53x suggest significant liquidity concerns and overvaluation compared to typical sector benchmarks. Furthermore, the return on capital employed (ROCE) of -5.14% indicates that the company is not generating adequate returns on its capital investment, which poses a risk to long-term sustainability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Chennai Meenakshi Multispeciality Hospital is predominantly held by promoters, who own 57.10% of the company, reflecting a stable control over operations. The public holds 42.75%, while domestic institutional investors (DIIs) have a negligible stake of 0.14%. The number of shareholders has increased to 8,671, suggesting a growing interest among small investors despite the company’s financial struggles. However, the lack of foreign institutional investor (FII) participation raises questions about broader market confidence in the hospital’s growth prospects. The low DII ownership might indicate hesitancy from institutional players, which could impact the company’s ability to attract future capital for expansion or improvements in operations.
Outlook, Risks, and Final Insight
Chennai Meenakshi Multispeciality Hospital faces several challenges that could affect its future performance. The ongoing volatility in revenue and profitability metrics suggests that operational efficiency must improve for sustainable growth. Risks include heightened competition in the healthcare sector and the hospital’s high leverage, which limits financial flexibility. Conversely, strengths such as a stable promoter holding and a robust cash conversion cycle could provide a foundation for recovery. If the hospital can successfully implement cost-control measures and enhance service offerings, it may reverse its declining profitability. However, without significant improvements in operational efficiency and financial health, the outlook remains uncertain. The company’s ability to attract institutional investment will also be critical in determining its long-term viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 45.0 Cr. | 134 | 187/120 | 9.19 | 117 | 2.60 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 20.8 Cr. | 19.9 | 33.0/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 10.4 Cr. | 10.0 | 20.5/7.08 | 116 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 102 Cr. | 54.4 | 98.7/52.2 | 22.5 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 18.0 Cr. | 3.33 | 6.74/3.28 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 24,508.79 Cr | 652.77 | 85.08 | 93.18 | 0.35% | 15.48% | 14.81% | 9.04 |
All Competitor Stocks of Chennai Meenakshi Multispeciality Hospital Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.10 | 7.63 | 9.88 | 9.07 | 9.51 | 10.07 | 9.55 | 8.75 | 8.07 | 8.83 | 9.17 | 8.65 | 9.47 |
| Expenses | 6.44 | 6.84 | 8.84 | 8.66 | 8.96 | 9.80 | 9.07 | 8.68 | 8.29 | 9.20 | 8.83 | 9.17 | 9.17 |
| Operating Profit | 0.66 | 0.79 | 1.04 | 0.41 | 0.55 | 0.27 | 0.48 | 0.07 | -0.22 | -0.37 | 0.34 | -0.52 | 0.30 |
| OPM % | 9.30% | 10.35% | 10.53% | 4.52% | 5.78% | 2.68% | 5.03% | 0.80% | -2.73% | -4.19% | 3.71% | -6.01% | 3.17% |
| Other Income | 0.08 | 0.10 | 0.11 | 0.10 | 0.04 | 0.15 | 0.18 | 0.08 | 0.08 | 0.26 | 0.42 | 0.27 | 0.34 |
| Interest | 0.22 | 0.22 | 0.22 | 0.23 | 0.23 | 0.23 | 0.24 | 0.24 | 0.23 | 0.23 | 0.22 | 0.22 | 0.23 |
| Depreciation | 0.29 | 0.29 | 0.29 | 0.27 | 0.30 | 0.30 | 0.29 | 0.31 | 0.31 | 0.31 | 0.23 | 0.29 | 0.28 |
| Profit before tax | 0.23 | 0.38 | 0.64 | 0.01 | 0.06 | -0.11 | 0.13 | -0.40 | -0.68 | -0.65 | 0.31 | -0.76 | 0.13 |
| Tax % | 0.00% | 0.00% | 60.94% | 0.00% | 33.33% | -63.64% | 446.15% | -5.00% | -1.47% | -3.08% | 3.23% | -1.32% | -15.38% |
| Net Profit | 0.23 | 0.38 | 0.25 | 0.02 | 0.04 | -0.04 | -0.44 | -0.38 | -0.67 | -0.63 | 0.31 | -0.74 | 0.15 |
| EPS in Rs | 0.31 | 0.51 | 0.33 | 0.03 | 0.05 | -0.05 | -0.59 | -0.51 | -0.90 | -0.84 | 0.42 | -0.99 | 0.20 |
Last Updated: December 27, 2025, 2:03 pm
Below is a detailed analysis of the quarterly data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9.47 Cr.. The value appears strong and on an upward trend. It has increased from 8.65 Cr. (Jun 2025) to 9.47 Cr., marking an increase of 0.82 Cr..
- For Expenses, as of Sep 2025, the value is 9.17 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.17 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Jun 2025) to 0.30 Cr., marking an increase of 0.82 Cr..
- For OPM %, as of Sep 2025, the value is 3.17%. The value appears strong and on an upward trend. It has increased from -6.01% (Jun 2025) to 3.17%, marking an increase of 9.18%.
- For Other Income, as of Sep 2025, the value is 0.34 Cr.. The value appears strong and on an upward trend. It has increased from 0.27 Cr. (Jun 2025) to 0.34 Cr., marking an increase of 0.07 Cr..
- For Interest, as of Sep 2025, the value is 0.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.22 Cr. (Jun 2025) to 0.23 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 0.28 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.29 Cr. (Jun 2025) to 0.28 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.13 Cr.. The value appears strong and on an upward trend. It has increased from -0.76 Cr. (Jun 2025) to 0.13 Cr., marking an increase of 0.89 Cr..
- For Tax %, as of Sep 2025, the value is -15.38%. The value appears to be improving (decreasing) as expected. It has decreased from -1.32% (Jun 2025) to -15.38%, marking a decrease of 14.06%.
- For Net Profit, as of Sep 2025, the value is 0.15 Cr.. The value appears strong and on an upward trend. It has increased from -0.74 Cr. (Jun 2025) to 0.15 Cr., marking an increase of 0.89 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.20. The value appears strong and on an upward trend. It has increased from -0.99 (Jun 2025) to 0.20, marking an increase of 1.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:58 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.59 | 18.71 | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 38.19 | 37.38 | 33.76 | 36.12 |
| Expenses | 15.21 | 16.57 | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 35.16 | 35.48 | 33.96 | 36.37 |
| Operating Profit | 2.38 | 2.14 | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 1.90 | -0.20 | -0.25 |
| OPM % | 13.53% | 11.44% | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 7.93% | 5.08% | -0.59% | -0.69% |
| Other Income | 0.30 | -0.54 | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.28 | 0.85 | 1.29 |
| Interest | 1.39 | 1.38 | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.92 | 0.91 | 0.90 |
| Depreciation | 0.81 | 1.19 | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 | 1.16 | 1.11 |
| Profit before tax | 0.48 | -0.97 | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.10 | -1.42 | -0.97 |
| Tax % | 8.33% | 0.00% | 0.00% | 0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | 530.00% | -3.52% | |
| Net Profit | 0.45 | -0.97 | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | -0.43 | -1.37 | -0.91 |
| EPS in Rs | 0.60 | -1.30 | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | -0.58 | -1.83 | -1.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -315.56% | 167.01% | -263.08% | 241.51% | -96.67% | 1000.00% | -327.27% | 418.40% | -77.64% | -148.31% | -218.60% |
| Change in YoY Net Profit Growth (%) | 0.00% | 482.57% | -430.09% | 504.59% | -338.18% | 1096.67% | -1327.27% | 745.67% | -496.04% | -70.68% | -70.29% |
Chennai Meenakshi Multispeciality Hospital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 26% |
| 3 Years: | 21% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:56 pm
Balance Sheet
Last Updated: December 4, 2025, 2:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Reserves | -11.97 | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.80 | -9.36 | -10.04 |
| Borrowings | 12.74 | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 11.42 | 10.63 | 10.63 |
| Other Liabilities | 10.98 | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.35 | 11.72 | 13.76 | 14.19 |
| Total Liabilities | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
| Fixed Assets | 15.11 | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 14.66 | 13.77 | 13.29 |
| CWIP | 0.47 | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.64 | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.16 | 8.15 | 8.73 | 8.96 |
| Total Assets | 19.22 | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 22.25 |
Below is a detailed analysis of the balance sheet data for Chennai Meenakshi Multispeciality Hospital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.47 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.47 Cr..
- For Reserves, as of Sep 2025, the value is -10.04 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -9.36 Cr. (Mar 2025) to -10.04 Cr., marking a decline of 0.68 Cr..
- For Borrowings, as of Sep 2025, the value is 10.63 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 10.63 Cr..
- For Other Liabilities, as of Sep 2025, the value is 14.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.76 Cr. (Mar 2025) to 14.19 Cr., marking an increase of 0.43 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22.25 Cr.. The value appears to be improving (decreasing). It has decreased from 22.50 Cr. (Mar 2025) to 22.25 Cr., marking a decrease of 0.25 Cr..
- For Fixed Assets, as of Sep 2025, the value is 13.29 Cr.. The value appears to be declining and may need further review. It has decreased from 13.77 Cr. (Mar 2025) to 13.29 Cr., marking a decrease of 0.48 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 8.96 Cr.. The value appears strong and on an upward trend. It has increased from 8.73 Cr. (Mar 2025) to 8.96 Cr., marking an increase of 0.23 Cr..
- For Total Assets, as of Sep 2025, the value is 22.25 Cr.. The value appears to be declining and may need further review. It has decreased from 22.50 Cr. (Mar 2025) to 22.25 Cr., marking a decrease of 0.25 Cr..
However, the Borrowings (10.63 Cr.) are higher than the Reserves (-10.04 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.36 | -9.99 | -9.18 | -10.94 | -8.45 | -10.10 | -9.03 | -10.84 | -4.89 | -7.60 | -9.52 | -10.83 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11.83 | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 11.28 | 6.25 | 8.65 |
| Inventory Days | 36.25 | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 | 21.50 | 24.49 |
| Days Payable | 112.88 | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 88.74 | 51.61 | 89.40 |
| Cash Conversion Cycle | -64.80 | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -54.75 | -23.85 | -56.26 |
| Working Capital Days | -171.61 | -185.72 | -143.60 | -178.91 | -123.83 | -125.76 | -95.83 | -170.78 | -81.73 | -67.28 | -74.02 | -98.71 |
| ROCE % | 22.61% | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% | 11.08% | -5.14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Diluted EPS (Rs.) | -1.84 | -0.60 | 1.19 | 5.32 | -1.67 |
| Cash EPS (Rs.) | -0.28 | 0.97 | 2.77 | 6.89 | 0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -2.53 | -0.43 | 0.16 | -1.04 | -6.39 |
| Revenue From Operations / Share (Rs.) | 46.62 | 51.15 | 38.25 | 42.02 | 26.08 |
| PBDIT / Share (Rs.) | 0.86 | 2.92 | 4.49 | 8.21 | 1.55 |
| PBIT / Share (Rs.) | -0.68 | 1.37 | 2.91 | 6.64 | -0.14 |
| PBT / Share (Rs.) | -1.91 | 0.13 | 1.71 | 5.32 | -1.67 |
| Net Profit / Share (Rs.) | -1.84 | -0.57 | 1.19 | 5.32 | -1.67 |
| PBDIT Margin (%) | 1.86 | 5.70 | 11.73 | 19.54 | 5.93 |
| PBIT Margin (%) | -1.47 | 2.67 | 7.60 | 15.80 | -0.56 |
| PBT Margin (%) | -4.10 | 0.27 | 4.48 | 12.66 | -6.41 |
| Net Profit Margin (%) | -3.94 | -1.11 | 3.11 | 12.66 | -6.41 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 732.31 | -511.80 | 0.00 |
| Return on Capital Employeed (%) | -5.00 | 8.42 | 18.60 | 46.54 | -1.49 |
| Return On Assets (%) | -6.10 | -1.87 | 3.95 | 18.58 | -6.50 |
| Long Term Debt / Equity (X) | -5.63 | -33.52 | 87.39 | -13.68 | -2.41 |
| Total Debt / Equity (X) | -5.63 | -34.86 | 87.39 | -13.68 | -2.41 |
| Asset Turnover Ratio (%) | 1.54 | 1.69 | 1.30 | 1.55 | 1.01 |
| Current Ratio (X) | 0.53 | 0.64 | 0.76 | 0.65 | 0.50 |
| Quick Ratio (X) | 0.49 | 0.60 | 0.72 | 0.62 | 0.45 |
| Inventory Turnover Ratio (X) | 83.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.71 | 2.37 | 3.76 | 6.23 | 1.02 |
| Interest Coverage Ratio (Post Tax) (X) | -0.50 | 0.53 | 2.00 | 5.04 | -0.09 |
| Enterprise Value (Cr.) | 30.27 | 32.82 | 19.95 | 24.68 | 15.65 |
| EV / Net Operating Revenue (X) | 0.86 | 0.85 | 0.69 | 0.78 | 0.80 |
| EV / EBITDA (X) | 46.65 | 15.06 | 5.95 | 4.02 | 13.54 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| Price / BV (X) | -12.21 | -77.01 | 114.51 | -22.26 | -1.53 |
| Price / Net Operating Revenue (X) | 0.66 | 0.65 | 0.48 | 0.55 | 0.37 |
| EarningsYield | -0.05 | -0.01 | 0.06 | 0.22 | -0.17 |
After reviewing the key financial ratios for Chennai Meenakshi Multispeciality Hospital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 5. It has decreased from -0.60 (Mar 24) to -1.84, marking a decrease of 1.24.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from 0.97 (Mar 24) to -0.28, marking a decrease of 1.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -2.53. It has decreased from -0.43 (Mar 24) to -2.53, marking a decrease of 2.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.62. It has decreased from 51.15 (Mar 24) to 46.62, marking a decrease of 4.53.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 2. It has decreased from 2.92 (Mar 24) to 0.86, marking a decrease of 2.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.37 (Mar 24) to -0.68, marking a decrease of 2.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.91. This value is below the healthy minimum of 0. It has decreased from 0.13 (Mar 24) to -1.91, marking a decrease of 2.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.84. This value is below the healthy minimum of 2. It has decreased from -0.57 (Mar 24) to -1.84, marking a decrease of 1.27.
- For PBDIT Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 10. It has decreased from 5.70 (Mar 24) to 1.86, marking a decrease of 3.84.
- For PBIT Margin (%), as of Mar 25, the value is -1.47. This value is below the healthy minimum of 10. It has decreased from 2.67 (Mar 24) to -1.47, marking a decrease of 4.14.
- For PBT Margin (%), as of Mar 25, the value is -4.10. This value is below the healthy minimum of 10. It has decreased from 0.27 (Mar 24) to -4.10, marking a decrease of 4.37.
- For Net Profit Margin (%), as of Mar 25, the value is -3.94. This value is below the healthy minimum of 5. It has decreased from -1.11 (Mar 24) to -3.94, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.00. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to -5.00, marking a decrease of 13.42.
- For Return On Assets (%), as of Mar 25, the value is -6.10. This value is below the healthy minimum of 5. It has decreased from -1.87 (Mar 24) to -6.10, marking a decrease of 4.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -5.63. This value is below the healthy minimum of 0.2. It has increased from -33.52 (Mar 24) to -5.63, marking an increase of 27.89.
- For Total Debt / Equity (X), as of Mar 25, the value is -5.63. This value is within the healthy range. It has increased from -34.86 (Mar 24) to -5.63, marking an increase of 29.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has decreased from 1.69 (Mar 24) to 1.54, marking a decrease of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1.5. It has decreased from 0.64 (Mar 24) to 0.53, marking a decrease of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.60 (Mar 24) to 0.49, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 83.36. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 83.36, marking an increase of 83.36.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 3. It has decreased from 2.37 (Mar 24) to 0.71, marking a decrease of 1.66.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 3. It has decreased from 0.53 (Mar 24) to -0.50, marking a decrease of 1.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 30.27. It has decreased from 32.82 (Mar 24) to 30.27, marking a decrease of 2.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.85 (Mar 24) to 0.86, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 46.65. This value exceeds the healthy maximum of 15. It has increased from 15.06 (Mar 24) to 46.65, marking an increase of 31.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For Price / BV (X), as of Mar 25, the value is -12.21. This value is below the healthy minimum of 1. It has increased from -77.01 (Mar 24) to -12.21, marking an increase of 64.80.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.66, marking an increase of 0.01.
- For EarningsYield, as of Mar 25, the value is -0.05. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.05, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chennai Meenakshi Multispeciality Hospital Ltd:
- Net Profit Margin: -3.94%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.49
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 85.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -5.63
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.94%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | New No.70, Old No.149, Chennai (Madras) Tamil Nadu 600004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. R Gomathi | Managing Director |
| Mrs. Jayanthi Radhakrishnan | Managing Director |
| Mr. Edward M Prabhakar | Non Executive Director |
| Mr. Akash Prabhakar | Non Executive Director |
| Mr. K Meyyanathan | Independent Director |
| Mr. N Rajkumar | Independent Director |
| Ms. Shama Dhilip | Ind. Non-Executive Director |
| Mr. K M Mohandass | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Chennai Meenakshi Multispeciality Hospital Ltd?
Chennai Meenakshi Multispeciality Hospital Ltd's intrinsic value (as of 27 January 2026) is ₹4.22 which is 89.71% lower the current market price of ₹41.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹30.6 Cr. market cap, FY2025-2026 high/low of ₹57.5/28.3, reserves of ₹-10.04 Cr, and liabilities of ₹22.25 Cr.
What is the Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd?
The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd is 30.6 Cr..
What is the current Stock Price of Chennai Meenakshi Multispeciality Hospital Ltd as on 27 January 2026?
The current stock price of Chennai Meenakshi Multispeciality Hospital Ltd as on 27 January 2026 is ₹41.0.
What is the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chennai Meenakshi Multispeciality Hospital Ltd stocks is ₹57.5/28.3.
What is the Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd?
The Stock P/E of Chennai Meenakshi Multispeciality Hospital Ltd is .
What is the Book Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Book Value of Chennai Meenakshi Multispeciality Hospital Ltd is 3.44.
What is the Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd?
The Dividend Yield of Chennai Meenakshi Multispeciality Hospital Ltd is 0.00 %.
What is the ROCE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROCE of Chennai Meenakshi Multispeciality Hospital Ltd is 5.14 %.
What is the ROE of Chennai Meenakshi Multispeciality Hospital Ltd?
The ROE of Chennai Meenakshi Multispeciality Hospital Ltd is %.
What is the Face Value of Chennai Meenakshi Multispeciality Hospital Ltd?
The Face Value of Chennai Meenakshi Multispeciality Hospital Ltd is 10.0.